Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: a randomised, 52-week, open-label, safety study

BACKGROUND: This 52-week study evaluated the long-term safety and tolerability of capsaicin 8% w/w (179 mg) patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy (PDPN). METHODS: Phase 3, multinational, open-label, randomised, controlled, 52-we...

Descripción completa

Detalles Bibliográficos
Autores principales: Vinik, Aaron I., Perrot, Serge, Vinik, Etta J., Pazdera, Ladislav, Jacobs, Hélène, Stoker, Malcolm, Long, Stephen K., Snijder, Robert J., van der Stoep, Marjolijne, Ortega, Enrique, Katz, Nathaniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5139122/
https://www.ncbi.nlm.nih.gov/pubmed/27919222
http://dx.doi.org/10.1186/s12883-016-0752-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5139122/
https://www.ncbi.nlm.nih.gov/pubmed/27919222
http://dx.doi.org/10.1186/s12883-016-0752-7

Ejemplares similares